Diffuse midline glioma treated with epigenetic agent-based immunotherapy

Signal Transduct Target Ther. 2023 Jan 20;8(1):23. doi: 10.1038/s41392-022-01274-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / therapy
  • Epigenesis, Genetic / genetics
  • Epigenomics
  • Glioma* / genetics
  • Glioma* / therapy
  • Humans